Why Janux Therapeutics Shares Rose 33.1% This Week

Why Janux Therapeutics Shares Rose 33.1% This Week

Submitted by admin on October 23, 2022 - 6:56pm
Source: 
Motley Fool
News Tags: 
Janux Therapeutics
oncology
JANX007
clinical trials
metastatic castration-resistant prostate cancer
Headline: 
Why Janux Therapeutics Shares Rose 33.1% This Week
snippet: 
  • Janux went public with an IPO last year.
  • The company plans a second investigational new drug application later this year.
  • Janux specializes in oncology therapies.

Do Not Allow Advertisers to Use My Personal information